ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 3 for:    Relugolix LIBERTY
Previous Study | Return to List | Next Study

LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03412890
Recruitment Status : Enrolling by invitation
First Posted : January 29, 2018
Last Update Posted : November 20, 2018
Sponsor:
Information provided by (Responsible Party):
Myovant Sciences GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : February 28, 2020
  Estimated Study Completion Date : July 30, 2020